Jupiter FY26 PAT INR194.2 Cr, Revenue Up 15.2%
Jupiter Life Line Hospitals reported FY26 PAT of INR194.2 crores, with total income increasing 15.2% to INR1,499.8 crores. Q4 revenue grew 15.1% to INR387.8 crores, with PAT rising 11.5% to INR50.2 crores. The company commissioned its Dombivli hospital and announced a new 400-bed facility in BKC, Mumbai.
*this image is generated using AI for illustrative purposes only.
Jupiter Life Line Hospitals Limited has released the transcript of its earnings conference call for the quarter and financial year ended March 31, 2026. The call was held on Monday, May 18, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company detailed its operational performance, expansion updates, and financial results for the period.
Financial Performance
For the full year FY26, the company reported a total income of INR1,499.8 crores, a year-on-year increase of 15.2%. EBITDA stood at INR343.3 crores, up 14.4%, with margins at 22.9%. Profit After Tax (PAT) for the year was INR194.2 crores. In the fourth quarter, revenue grew 15.1% to INR387.8 crores. EBITDA for the quarter was INR89.2 crores, representing a 23% margin, while PAT increased 11.5% to INR50.2 crores.
| Metric | FY26 Value | YoY Change |
|---|---|---|
| Total Income | INR1,499.8 crores | +15.2% |
| EBITDA | INR343.3 crores | +14.4% |
| PAT | INR194.2 crores | - |
| Q4 Revenue | INR387.8 crores | +15.1% |
| Q4 PAT | INR50.2 crores | +11.5% |
Operational Metrics
Average Revenue Per Occupied Bed (ARPOB) grew 11.7% to INR67,700. The Average Length of Stay (ALOS) was 3.87 days, and bed occupancy for the three pre-existing hospitals stood at 61.2%. Overall volumes increased 9.9% to 10.8 lakhs, with growth in both outpatient (OP) and inpatient (IP) numbers. Insurance revenues accounted for 55.4% of the revenue mix, while government revenue stood at 1%.
Expansion and Capex
The company commissioned its Dombivli hospital in February 2026, featuring a 750,000 square feet superstructure for 500 beds with initial fit-outs for 300 beds. Management expects the facility to achieve EBITDA breakeven by the end of two years of operations. Other projects, including Pune South and Mira Road, are progressing as planned. The company also announced plans for a new 400-bed quaternary care hospital in BKC, Mumbai. For the expansion cycle, the company anticipates adding approximately 1,700 new beds at an average cost of INR1.5 crores per bed.
Financial Position
Jupiter Life Line Hospitals deployed around INR500 crores in capital expenditure during the year. Despite this, the company remains net cash positive, with gross debt at around INR500 crores and cash on hand of approximately INR545 crores. Management stated that internal accruals over the next four years, combined with debt maintained at under three times EBITDA, should be sufficient to fund announced projects.
How quickly could the Dombivli hospital ramp up occupancy rates compared to Jupiter's existing facilities, and what patient catchment strategies are planned for the new market?
Given that insurance revenues already account for 55.4% of the revenue mix, how might further insurance penetration or policy changes impact Jupiter's pricing power and ARPOB growth trajectory?
With the BKC quaternary care hospital announced and 1,700 beds in the pipeline, how will Jupiter manage execution risk and potential cost overruns given rising construction and medical equipment costs?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
